Details for New Drug Application (NDA): 010060
✉ Email this page to a colleague
NDA 010060 describes FLORINEF, which is a drug marketed by Casper Pharma Llc and is included in one NDA. Additional details are available on the FLORINEF profile page.
The generic ingredient in FLORINEF is fludrocortisone acetate. There are four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fludrocortisone acetate profile page.
The generic ingredient in FLORINEF is fludrocortisone acetate. There are four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fludrocortisone acetate profile page.
Summary for 010060
| Tradename: | FLORINEF |
| Applicant: | Casper Pharma Llc |
| Ingredient: | fludrocortisone acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 010060
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
